Hormone Receptors in Neurofibromas of NF1 Patients
Author Information
Author(s): Mauro Geller, Spyros G.E. Mezitis, Fabio Pereira Nunes, Marcia G. Ribeiro, Alexandra Prufer de Q.C. Araújo, Marcello D. Bronstein, Rodrigo Siqueira-Batista, Andréia Patrícia Gomes, Lisa Oliveira, Karin Soares Gonçalves Cunha
Primary Institution: Centro Nacional de Neurofibromatose (CNNF-Brazil)
Hypothesis
This study aims to observe the presence of progesterone and estrogen receptors in neurofibromas and plexiform neurofibromas of NF1 patients.
Conclusion
The study confirms the presence of progesterone receptors in both neurofibromas and plexiform neurofibromas in NF1 patients, suggesting hormonal influences on tumor growth.
Supporting Evidence
- Positive progesterone receptor staining was found in 13 of the plexiform neurofibroma samples.
- Only one neurofibroma sample showed positive estrogen receptor staining.
- No significant difference in hormone receptor positivity was observed between male and female patients.
Takeaway
The researchers looked at tumors from patients with a genetic condition and found that many had a specific hormone receptor, which might help explain why these tumors grow quickly at certain times.
Methodology
The study involved a descriptive case study on 50 NF1 patients, testing tissue samples for hormone receptors using immunohistochemistry.
Limitations
The study excluded patients with a history of malignant tumors, which may limit the generalizability of the findings.
Participant Demographics
The N1 group had 13 male and 12 female patients, while the N2 group had 10 male and 15 female patients.
Statistical Information
P-Value
p = 1.000
Statistical Significance
p = 1.000
Want to read the original?
Access the complete publication on the publisher's website